Skip to content
10-K

Annual Report

Korro Bio, Inc. KRRO

0001193125-26-104156

← back to feed
Filed
Mar 12, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 10, 2026 14.42M sh
Shares Diluted FY 2025 · Dec 31, 2025 9.4M sh
Shares Diluted FY 2025 · Dec 31, 2024 8.92M sh
Capex FY 2025 · Dec 31, 2025 $518K
Capex FY 2025 · Dec 31, 2024 $17.9M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$78.56M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$60.07M
Cash And Equivalents FY 2025 · Dec 31, 2025 $21.82M
Cash And Equivalents FY 2025 · Dec 31, 2024 $55.64M
Stockholders Equity FY 2025 · Dec 31, 2025 $51.44M
Stockholders Equity FY 2025 · Dec 31, 2024 $160.42M
Stockholders Equity FY 2025 · Dec 31, 2023 $169.91M
Current Liabilities FY 2025 · Dec 31, 2025 $11.94M
Current Liabilities FY 2025 · Dec 31, 2024 $14.96M
Total Liabilities FY 2025 · Dec 31, 2025 $62.07M
Total Liabilities FY 2025 · Dec 31, 2024 $65.83M
Current Assets FY 2025 · Dec 31, 2025 $82.37M
Current Assets FY 2025 · Dec 31, 2024 $131.53M
Total Assets FY 2025 · Dec 31, 2025 $113.51M
Total Assets FY 2025 · Dec 31, 2024 $226.24M
Eps Diluted FY 2025 · Dec 31, 2025 −$12.48
Eps Diluted FY 2025 · Dec 31, 2024 −$9.37
Eps Basic FY 2025 · Dec 31, 2025 −$12.48
Eps Basic FY 2025 · Dec 31, 2024 −$9.37
Sga Expense FY 2025 · Dec 31, 2025 $28.16M
Sga Expense FY 2025 · Dec 31, 2024 $30.55M
Rd Expense FY 2025 · Dec 31, 2025 $65.58M
Rd Expense FY 2025 · Dec 31, 2024 $63.64M
Net Income FY 2025 · Dec 31, 2025 −$117.26M
Net Income FY 2025 · Dec 31, 2024 −$83.58M
Operating Income FY 2025 · Dec 31, 2025 −$121.86M
Operating Income FY 2025 · Dec 31, 2024 −$91.91M